Pathobionts of the gastrointestinal microbiota and inflammatory disease

Current Opinion in Immunology

Volumn 23, Issue 4, 2011, Pages 473-480

  Chow, Janet ^a   Tang, Haiqing ^a   Mazmanian, Sarkis K ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 17R; INTERLEUKIN 22; INTERLEUKIN 23; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACTINOBACTERIA; ADAPTIVE IMMUNITY; BACTERIAL COLONIZATION; BACTEROIDETES; CITROBACTER RODENTIUM; CLOSTRIDIUM; COLITIS; COLORECTAL CANCER; CROHN DISEASE; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM CANCER; DISEASE PREDISPOSITION; ENTERITIS; ENTEROINVASIVE ESCHERICHIA COLI; ENVIRONMENTAL FACTOR; FIRMICUTES; GASTRITIS; GENE; GENETIC POLYMORPHISM; HELICOBACTER HEPATICUS; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; IL10 GENE; IL1BETA GENE; IL23R GENE; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTESTINE FLORA; IRGM GENE; KLEBSIELLA PNEUMONIAE; MICROENVIRONMENT; NOD2 GENE; NONHUMAN; PEPTIC ULCER; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOBACTERIA; PROTEUS MIRABILIS; REVIEW; RISK FACTOR; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; TH17 CELL; TLR GENE; ULCERATIVE COLITIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; COCARCINOGENESIS; COLORECTAL NEOPLASMS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GASTROINTESTINAL TRACT; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFLAMMATORY BOWEL DISEASES; METAGENOME; MICE; MICE, SCID; MODELS, BIOLOGICAL; SPECIES SPECIFICITY; SUPERINFECTION; SYMBIOSIS;

EID: 80052365606     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2011.07.010     Document Type: Review

References (68)

1. Ley R.E., Peterson D.A., Gordon J.I. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124:837-848.
2. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
3. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
4. Peterson J., Garges S., Giovanni M., McInnes P., Wang L., Schloss J.A., Bonazzi V., McEwen J.E., Wetterstrand K.A., Deal C., et al. The NIH human microbiome project. Genome Res 2009, 19:2317-2323.
5. Garrett W.S., Lord G.M., Punit S., Lugo-Villarino G., Mazmanian S.K., Ito S., Glickman J.N., Glimcher L.H. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007, 131:33-45.
6. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010, 107:12204-12209.
7. Ivanov I.I., Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., Wei D., Goldfarb K.C., Santee C.A., Lynch S.V., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
8. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., Cheng G., Yamasaki S., Saito T., Ohba Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
9. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
10. Talham G.L., Jiang H.Q., Bos N.A., Cebra J.J. Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system. Infect Immun 1999, 67:1992-2000.
11. Gaboriau-Routhiau V., Rakotobe S., Lecuyer E., Mulder I., Lan A., Bridonneau C., Rochet V., Pisi A., De Paepe M., Brandi G., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
12. Ivanov I.I., Frutos Rde L., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., Finlay B.B., Littman D.R. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
13. Niess J.H., Leithauser F., Adler G., Reimann J. Commensal gut flora drives the expansion of proinflammatory CD4 T cells in the colonic lamina propria under normal and inflammatory conditions. J Immunol 2008, 180:559-568.
14. Atarashi K., Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., Yagita H., Ishii N., Evans R., Honda K., et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 2008, 455:808-812.
15. Stepankova R., Powrie F., Kofronova O., Kozakova H., Hudcovic T., Hrncir T., Uhlig H., Read S., Rehakova Z., Benada O., et al. Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis 2007, 13:1202-1211.
16. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., Littman D.R., Benoist C., Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
17. Lee Y.K., Menezes J.S., Umesaki Y., Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2011, 108(Suppl. 1):4615-4622.
18. Solnick J.V., Schauer D.B. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev 2001, 14:59-97.
19. Taylor N.S., Xu S., Nambiar P., Dewhirst F.E., Fox J.G. Enterohepatic Helicobacter species are prevalent in mice from commercial and academic institutions in Asia, Europe, and North America. J Clin Microbiol 2007, 45:2166-2172.
20. Ward J.M., Fox J.G., Anver M.R., Haines D.C., George C.V., Collins M.J., Gorelick P.L., Nagashima K., Gonda M.A., Gilden R.V., et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994, 86:1222-1227.
21. Ward J.M., Anver M.R., Haines D.C., Melhorn J.M., Gorelick P., Yan L., Fox J.G. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab Anim Sci 1996, 46:15-20.
22. Li X., Fox J.G., Whary M.T., Yan L., Shames B., Zhao Z. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect Immun 1998, 66:5477-5484.
23. Cahill R.J., Foltz C.J., Fox J.G., Dangler C.A., Powrie F., Schauer D.B. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997, 65:3126-3131.
24. Kullberg M.C., Ward J.M., Gorelick P.L., Caspar P., Hieny S., Cheever A., Jankovic D., Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect Immun 1998, 66:5157-5166.
25. Erdman S.E., Poutahidis T., Tomczak M., Rogers A.B., Cormier K., Plank B., Horwitz B.H., Fox J.G. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol 2003, 162:691-702.
26. Kullberg M.C., Andersen J.F., Gorelick P.L., Caspar P., Suerbaum S., Fox J.G., Cheever A.W., Jankovic D., Sher A. Induction of colitis by a CD4+ T cell clone specific for a bacterial epitope. Proc Natl Acad Sci U S A 2003, 100:15830-15835.
27. Matharu K.S., Mizoguchi E., Cotoner C.A., Nguyen D.D., Mingle B., Iweala O.I., McBee M.E., Stefka A.T., Prioult G., Haigis K.M., et al. Toll-like receptor 4-mediated regulation of spontaneous Helicobacter-dependent colitis in IL-10-deficient mice. Gastroenterology 2009, 137. 1380-1390 e1381-1383.
28. Erdman S.E., Rao V.P., Poutahidis T., Rogers A.B., Taylor C.L., Jackson E.A., Ge Z., Lee C.W., Schauer D.B., Wogan G.N., et al. Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A 2009, 106:1027-1032.
29. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., Powrie F., Maloy K.J. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006, 203:2473-2483.
30. Asquith M.J., Boulard O., Powrie F., Maloy K.J. Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology 2010, 139. 519-529, 529 e511-512.
31. Fox J.G., Ge Z., Whary M.T., Erdman S.E., Horwitz B.H. Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol 2011, 4:22-30.
32. Kullberg M.C., Jankovic D., Gorelick P.L., Caspar P., Letterio J.J., Cheever A.W., Sher A. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002, 196:505-515.
33. Maloy K.J., Salaun L., Cahill R., Dougan G., Saunders N.J., Powrie F. CD4+ CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003, 197:111-119.
34. Tomczak M.F., Erdman S.E., Davidson A., Wang Y.Y., Nambiar P.R., Rogers A.B., Rickman B., Luchetti D., Fox J.G., Horwitz B.H. Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B. J Immunol 2006, 177:7332-7339.
35. Sterzenbach T., Lee S.K., Brenneke B., von Goetz F., Schauer D.B., Fox J.G., Suerbaum S., Josenhans C. Inhibitory effect of enterohepatic Helicobacter hepaticus on innate immune responses of mouse intestinal epithelial cells. Infect Immun 2007, 75:2717-2728.
36. Chow J., Mazmanian S.K. A pathobiont of the microbiota balances host colonization and intestinal inflammation. Cell Host Microbe 2010, 7:265-276.
37. Dorer M.S., Talarico S., Salama N.R. Helicobacter pylori's unconventional role in health and disease. PLoS Pathog 2009, 5:e1000544.
38. Odenbreit S., Puls J., Sedlmaier B., Gerland E., Fischer W., Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000, 287:1497-1500.
39. Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010, 10:403-414.
40. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A., Herrera J., Lissowska J., Yuan C.C., Rothman N., et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000, 404:398-402.
41. Sonnenberg A., Lash R.H., Genta R.M. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 2010, 139. 1894-1901 e2 (quiz e12).
42. Chen Y., Blaser M.J. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008, 198:553-560.
43. Chow W.H., Blaser M.J., Blot W.J., Gammon M.D., Vaughan T.L., Risch H.A., Perez-Perez G.I., Schoenberg J.B., Stanford J.L., Rotterdam H., et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998, 58:588-590.
44. Willyard C. A tough controversy to stomach. Nat Med 2009, 15:836-839.
45. Gressmann H., Linz B., Ghai R., Pleissner K.P., Schlapbach R., Yamaoka Y., Kraft C., Suerbaum S., Meyer T.F., Achtman M. Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet 2005, 1:e43.
46. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
47. Kinross J.M., von Roon A.C., Holmes E., Darzi A., Nicholson J.K. The human gut microbiome: implications for future health care. Curr Gastroenterol Rep 2008, 10:396-403.
48. Garrett W.S., Punit S., Gallini C.A., Michaud M., Zhang D., Sigrist K.S., Lord G.M., Glickman J.N., Glimcher L.H. Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell 2009, 16:208-219.
49. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., Punit S., Karlsson M., Bry L., Glickman J.N., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
50. Scanlan P.D., Shanahan F., O'Mahony C., Marchesi J.R. Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease. J Clin Microbiol 2006, 44:3980-3988.
51. Frank D.N., St Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 2007, 104:13780-13785.
52. Macpherson A., Khoo U.Y., Forgacs I., Philpott-Howard J., Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996, 38:365-375.
53. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126:1620-1633.
54. Nell S., Suerbaum S., Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010, 8:564-577.
55. Barrett J.C., Hansoul S., Nicolae D.L., Cho J.H., Duerr R.H., Rioux J.D., Brant S.R., Silverberg M.S., Taylor K.D., Barmada M.M., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
56. Salzman N.H., Hung K., Haribhai D., Chu H., Karlsson-Sjoberg J., Amir E., Teggatz P., Barman M., Hayward M., Eastwood D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010, 11:76-83.
57. Elinav E., Strowig T., Kau A.L., Henao-Mejia J., Thaiss C.A., Booth C.J., Peaper D.R., Bertin J., Eisenbarth S.C., Gordon J.I., et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145:745-757.
58. Palmer R. Fecal matters. Nat Med 2011, 17:150-152.
59. Ubeda C., Taur Y., Jenq R.R., Equinda M.J., Son T., Samstein M., Viale A., Socci N.D., van den Brink M.R., Kamboj M., et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 2010, 120:4332-4341.
60. Brandl K., Plitas G., Mihu C.N., Ubeda C., Jia T., Fleisher M., Schnabl B., DeMatteo R.P., Pamer E.G. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
61. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008, 454:436-444.
62. McConnell B.B., Yang V.W. The role of inflammation in the pathogenesis of colorectal cancer. Curr Colorectal Cancer Rep 2009, 5:69-74.
63. Uronis J.M., Muhlbauer M., Herfarth H.H., Rubinas T.C., Jones G.S., Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 2009, 4:e6026.
64. Engle S.J., Ormsby I., Pawlowski S., Boivin G.P., Croft J., Balish E., Doetschman T. Elimination of colon cancer in germ-free transforming growth factor beta 1-deficient mice. Cancer Res 2002, 62:6362-6366.
65. Kado S., Uchida K., Funabashi H., Iwata S., Nagata Y., Ando M., Onoue M., Matsuoka Y., Ohwaki M., Morotomi M. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res 2001, 61:2395-2398.
66. Swidsinski A., Khilkin M., Kerjaschki D., Schreiber S., Ortner M., Weber J., Lochs H. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998, 115:281-286.
67. Martin H.M., Campbell B.J., Hart C.A., Mpofu C., Nayar M., Singh R., Englyst H., Williams H.F., Rhodes J.M. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004, 127:80-93.
68. Wilmink A.B. Overview of the epidemiology of colorectal cancer. Dis Colon Rectum 1997, 40:483-493.